MedTrace Logo

Neoadjuvant PDT in the Treatment of Cholangiocarcinoma

NCT04824742 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-04-01

No results posted yet for this study

Summary

For patients with locally advanced cholangiocarcinoma with resectable margins, patients who meet the selection criteria are randomly divided into two groups A and B. Group A: neoadjuvant PDT therapy combined with radical surgery; Group B: radical surgery. This study aims to explore the clinical effectiveness and safety of neoadjuvant photodynamic therapy for cholangiocarcinoma, as well as its role in destroying local tumors and enhancing systemic inflammation.

Conditions

  • Cholangiocarcinoma Resectable

Interventions

PROCEDURE

Neoadjuvant PDT + radical surgery

Patients with cholangiocarcinoma will undergo radical surgery after photodynamic therapy

PROCEDURE

Radical surgery

Patients with cholangiocarcinoma will only receive radical surgery

Sponsors & Collaborators

  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Yi Lv, MD,PHD · China, Shaanxi First Affiliated Hospital of Xian JiaotongUniversity

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2023-04-01
Completion
2028-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04824742 on ClinicalTrials.gov